Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival

The metabolic pathway of de novo lipogenesis is frequently upregulated in human liver tumours, and its upregulation is associated with poor prognosis. Blocking lipogenesis in cultured liver cancer cells is sufficient to decrease cell viability; however, it is not known whether blocking lipogenesis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Marin E., Lahiri, Sujoy, Chow, Jenny D. Y., Byrne, Frances L., Hargett, Stefan R., Breen, David S., Olzomer, Ellen M., Wu, Lindsay E., Cooney, Gregory J., Turner, Nigel, James, David E., Slack-Davis, Jill K., Lackner, Carolin, Caldwell, Stephen H., Hoehn, Kyle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424065/
https://www.ncbi.nlm.nih.gov/pubmed/28290443
http://dx.doi.org/10.1038/ncomms14689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424065/
https://www.ncbi.nlm.nih.gov/pubmed/28290443
http://dx.doi.org/10.1038/ncomms14689

Ejemplares similares